FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1972084457> ?p ?o ?g. }

• W1972084457 endingPage "e62736" @default.
• W1972084457 startingPage "e62736" @default.
• W1972084457 abstract "Background Laboratory research and previous study suggest that aliskiren, a direct renin inhibitor, has anti-proteinuric effects. We conducted a randomized crossover study to evaluate the anti-proteinuric effect of aliskiren in patients with immunoglobulin A (IgA) nephropathy. Methods We studied 22 patients with biopsy-proven IgA nephropathy and persistent proteinuria despite angiotensin converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB). Patients were randomized to either oral aliskiren 300 mg/day or placebo for 16 weeks and then crossed over to the other treatment arm after a washout period. Proteinuria, estimated glomerular filtration rate (eGFR), blood pressure, and serum potassium were monitored. Results After aliskiren treatment, there was a significant reduction in proteinuria in 4 weeks (1.76±0.95 to 1.03±0.69 g:g-Cr, p<0.0001), which remained at a low level throughout the treatment period. There was a significant difference in proteinuria between the aliskiren and placebo groups from 4 to 16 weeks after treatment (p<0.01 for all comparisons). After aliskiren treatment, there were modest but statistically significant reductions in eGFR (57.2±29.1 to 54.8±29.3 ml/min/1.73 m2, p = 0.013) and diastolic blood pressure (72.6±12.3 to 66.2±11.2 mmHg, p<0.0001). None of the patient developed severe hyperkalemia (serum potassium ≥6.0 mmol/l) during the study period. Conclusions Aliskiren has anti-proteinuric effect in patients with IgA nephropathy and persistent proteinuria despite ACE inhibitor or ARB. Further studies are needed to confirm the renal protecting effect of direct renin inhibition in chronic proteinuric kidney diseases. Trial Registration ClinicalTrials.gov NCT00870493" @default.
• W1972084457 created "2016-06-24" @default.
• W1972084457 creator A5000398237 @default.
• W1972084457 creator A5006663907 @default.
• W1972084457 creator A5007190507 @default.
• W1972084457 creator A5063429550 @default.
• W1972084457 creator A5070401295 @default.
• W1972084457 date "2013-05-10" @default.
• W1972084457 modified "2023-09-26" @default.
• W1972084457 title "The Safety and Short-Term Efficacy of Aliskiren in the Treatment of Immunoglobulin A Nephropathy – A Randomized Cross-Over Study" @default.
• W1972084457 cites W1971086200 @default.
• W1972084457 cites W1982085852 @default.
• W1972084457 cites W1998434576 @default.
• W1972084457 cites W2002816750 @default.
• W1972084457 cites W2004857031 @default.
• W1972084457 cites W2015569360 @default.
• W1972084457 cites W2034660243 @default.
• W1972084457 cites W2054779315 @default.
• W1972084457 cites W2059356953 @default.
• W1972084457 cites W2060993823 @default.
• W1972084457 cites W2083762853 @default.
• W1972084457 cites W2093276210 @default.
• W1972084457 cites W2094005904 @default.
• W1972084457 cites W2097933281 @default.
• W1972084457 cites W2106802067 @default.
• W1972084457 cites W2107914594 @default.
• W1972084457 cites W2117083889 @default.
• W1972084457 cites W2118795730 @default.
• W1972084457 cites W2122744112 @default.
• W1972084457 cites W2125719342 @default.
• W1972084457 cites W2138862624 @default.
• W1972084457 cites W2145632481 @default.
• W1972084457 cites W2145732657 @default.
• W1972084457 cites W2150719216 @default.
• W1972084457 cites W2151295696 @default.
• W1972084457 cites W2152798629 @default.
• W1972084457 cites W2152853007 @default.
• W1972084457 cites W2160407912 @default.
• W1972084457 cites W2162369893 @default.
• W1972084457 cites W2166819422 @default.
• W1972084457 cites W2319486435 @default.
• W1972084457 doi "https://doi.org/10.1371/journal.pone.0062736" @default.
• W1972084457 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3651209" @default.
• W1972084457 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23675422" @default.
• W1972084457 hasPublicationYear "2013" @default.
• W1972084457 type Work @default.
• W1972084457 sameAs 1972084457 @default.
• W1972084457 citedByCount "18" @default.
• W1972084457 countsByYear W19720844572013 @default.
• W1972084457 countsByYear W19720844572015 @default.
• W1972084457 countsByYear W19720844572016 @default.
• W1972084457 countsByYear W19720844572017 @default.
• W1972084457 countsByYear W19720844572018 @default.
• W1972084457 countsByYear W19720844572019 @default.
• W1972084457 countsByYear W19720844572021 @default.
• W1972084457 countsByYear W19720844572023 @default.
• W1972084457 crossrefType "journal-article" @default.
• W1972084457 hasAuthorship W1972084457A5000398237 @default.
• W1972084457 hasAuthorship W1972084457A5006663907 @default.
• W1972084457 hasAuthorship W1972084457A5007190507 @default.
• W1972084457 hasAuthorship W1972084457A5063429550 @default.
• W1972084457 hasAuthorship W1972084457A5070401295 @default.
• W1972084457 hasBestOaLocation W19720844571 @default.
• W1972084457 hasConcept C126322002 @default.
• W1972084457 hasConcept C126894567 @default.
• W1972084457 hasConcept C134018914 @default.
• W1972084457 hasConcept C142724271 @default.
• W1972084457 hasConcept C159641895 @default.
• W1972084457 hasConcept C198710026 @default.
• W1972084457 hasConcept C204787440 @default.
• W1972084457 hasConcept C27016395 @default.
• W1972084457 hasConcept C27081682 @default.
• W1972084457 hasConcept C2779561371 @default.
• W1972084457 hasConcept C2779611605 @default.
• W1972084457 hasConcept C2779838083 @default.
• W1972084457 hasConcept C2780091579 @default.
• W1972084457 hasConcept C2780243291 @default.
• W1972084457 hasConcept C2781184683 @default.
• W1972084457 hasConcept C555293320 @default.
• W1972084457 hasConcept C71924100 @default.
• W1972084457 hasConcept C84393581 @default.
• W1972084457 hasConcept C87813604 @default.
• W1972084457 hasConcept C90924648 @default.
• W1972084457 hasConceptScore W1972084457C126322002 @default.
• W1972084457 hasConceptScore W1972084457C126894567 @default.
• W1972084457 hasConceptScore W1972084457C134018914 @default.
• W1972084457 hasConceptScore W1972084457C142724271 @default.
• W1972084457 hasConceptScore W1972084457C159641895 @default.
• W1972084457 hasConceptScore W1972084457C198710026 @default.
• W1972084457 hasConceptScore W1972084457C204787440 @default.
• W1972084457 hasConceptScore W1972084457C27016395 @default.
• W1972084457 hasConceptScore W1972084457C27081682 @default.
• W1972084457 hasConceptScore W1972084457C2779561371 @default.
• W1972084457 hasConceptScore W1972084457C2779611605 @default.
• W1972084457 hasConceptScore W1972084457C2779838083 @default.
• W1972084457 hasConceptScore W1972084457C2780091579 @default.
• W1972084457 hasConceptScore W1972084457C2780243291 @default.
• W1972084457 hasConceptScore W1972084457C2781184683 @default.

• next